Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
HY Chen, DT Shen, DZ Ji, PC Han, WM Zhang, JF Ma… - Gut, 2019 - gut.bmj.com
Objective Hepatitis D virus (HDV) is a defective virus that completes its life cycle only with
hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of …
hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of …
The changing context of hepatitis D
The global epidemiology of hepatitis D is changing with the widespread implementation of
vaccination against hepatitis B. In high-income countries that achieved optimal control of …
vaccination against hepatitis B. In high-income countries that achieved optimal control of …
EASL Clinical Practice Guidelines on hepatitis delta virus
Hepatitis D virus (HDV) is a defective virus that requires the hepatitis B virus to complete its
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
Cohort profile update: the Swiss HIV cohort study (SHCS)
AU Scherrer, A Traytel, DL Braun… - International journal …, 2022 - academic.oup.com
The Swiss HIV Cohort Study (SHCS) provides a unique research platform for clinical,
translational, epidemiological, social and basic research. The SHCS was established in …
translational, epidemiological, social and basic research. The SHCS was established in …
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Y Wang, B Deng - Cancer and Metastasis Reviews, 2023 - Springer
Hepatocellular carcinoma (HCC) is a common malignancy and one of the leading causes of
cancer-related death. The biological process of HCC is complex, with multiple factors …
cancer-related death. The biological process of HCC is complex, with multiple factors …
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies
Background & Aims Chronic hepatitis D (CHD) is the most severe form of chronic viral
hepatitis but its role in the development of hepatocellular carcinoma (HCC) remains …
hepatitis but its role in the development of hepatocellular carcinoma (HCC) remains …
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Background Hepatitis D is the most severe form of chronic viral hepatitis. Treatment
guidelines recommend 1 year of peginterferon alfa, which is effective in 25–30% of patients …
guidelines recommend 1 year of peginterferon alfa, which is effective in 25–30% of patients …
[HTML][HTML] A review on hepatitis D: From virology to new therapies
N Mentha, S Clément, F Negro, D Alfaiate - Journal of advanced research, 2019 - Elsevier
Hepatitis delta virus (HDV) is a defective virus that requires the hepatitis B virus (HBV) to
complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating …
complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating …
[PDF][PDF] Long‐term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver‐related outcomes
H Kamal, G Westman, K Falconer, AS Duberg… - …, 2020 - Wiley Online Library
Background and Aims Hepatitis delta virus (HDV) infection is associated with fast
progression to liver cirrhosis and liver complications. Previous studies have, however, been …
progression to liver cirrhosis and liver complications. Previous studies have, however, been …
Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy
Chronic hepatitis delta represents the most severe form of chronic viral hepatitis. The current
treatment of hepatitis delta virus (HDV) infection consists of the use of interferons and is …
treatment of hepatitis delta virus (HDV) infection consists of the use of interferons and is …